Small molecule inhibitors reveal an indispensable scaffolding role of RIPK2 in NOD2 signaling
Open Access
- 19 July 2018
- journal article
- research article
- Published by Springer Nature in The EMBO Journal
- Vol. 37 (17)
Abstract
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.Keywords
Funding Information
- Eshelman Innovation
- Allergopharma
- Novartis Pharma
- Wellcome Trust (106169/ZZ14/Z)
- Wellcome Trust (095751/Z/11/Z)
- Wellcome Trust (102894/Z/13/Z)
- Takeda Pharmaceutical Company
- Forskerakademiet
- Ministerstvo Vnitra České Republiky (18‐24070Y)
- European Molecular Biology Organization
- Ludwig Institute for Cancer Research
- AbbVie
- Bayer
- Boehringer Ingelheim
- Canada Foundation for Innovation
- Genome Canada
- Erzincan Üniversitesi (ULTRA‐DD 115766)
- Janssen
- Meso Scale Diagnostics
- Ontario Ministry of Economic Development and Innovation
- Pfizer
- Fundação de Amparo à Pesquisa do Estado de São Paulo
- Myeloma UK
- American Heart Association (15GRNT22970025)
- National Institutes of Health (R01CA190542)
- National Institutes of Health (R21AI124049)
This publication has 67 references indexed in Scilit:
- The mechanism of activation of IRAK1 and IRAK4 by interleukin-1 and Toll-like receptor agonistsBiochemical Journal, 2017
- From Genes to MechanismsInflammatory Bowel Diseases, 2016
- Autoinflammatory granulomatous diseases: from Blau syndrome and early-onset sarcoidosis to NOD2-mediated disease and Crohn's diseaseRMD Open, 2015
- FDA-approved small-molecule kinase inhibitorsTrends in Pharmacological Sciences, 2015
- Structure Guided Design of Potent and Selective Ponatinib-Based Hybrid Inhibitors for RIPK1Cell Reports, 2015
- NOD2 downregulates colonic inflammation by IRF4-mediated inhibition of K63-linked polyubiquitination of RICK and TRAF6Mucosal Immunology, 2014
- X-linked inhibitor of apoptosis (XIAP) deficiency: The spectrum of presenting manifestations beyond hemophagocytic lymphohistiocytosisClinical Immunology, 2013
- OTULIN Restricts Met1-Linked Ubiquitination to Control Innate Immune SignalingMolecular Cell, 2013
- A critical role of RICK/RIP2 polyubiquitination in Nod‐induced NF‐κB activationThe EMBO Journal, 2007
- Early-onset sarcoidosis and CARD15 mutations with constitutive nuclear factor- B activation: common genetic etiology with Blau syndromeBlood, 2004